Welcome

Moderna Backtracks to Open Covid Vaccine Trial to Those With HIV

Aug. 6, 2020, 8:05 PM

After pressure from advocates in recent weeks, Moderna Inc. will now allow individuals living with HIV to be part of a late-stage clinical trial of its Covid-19 vaccine candidate.

Moderna had previously said it would exclude people with HIV from the trial.

The biotechnology company said Wednesday that it’s “committed to working with all communities who could benefit from our Covid-19 vaccine” and added those with “controlled HIV who are not otherwise immunosuppressed” to the protocols, after talking to government partners. Moderna said it planned to test the drug in people with HIV in a separate study.

“Aren’t we trying ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.